Skip to main content

Table 1 Phase I study of DC-based therapy against high-grade glioma

From: α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial

Patient no. Age Sex Previous therapy PS Pathological diagnosis (WHO grade)
1 69 M ST, CT 1 GBM (IV)
2 49 M ST, CT, RT 0 AO (III)
3 38 M ST, CT, RT 2 GBM (IV)
4 32 F CT, RT, 2 AA (III)
5 61 M ST, CT, RT 1 GBM (IV)
6 32 M ST, CT, RT 1 GBM (IV)
7 73 M ST, CT, RT 1 GBM (IV)
8 53 F ST, CT, 1 GBM (IV)
9 31 M ST, CT, 1 GBM (IV)
  1. ST; surgical therapy, CT; chemotherapy, RT; radiation therapy.
  2. GBM; glioblastoma multiforme, AO; anaplastic oligodendroglioma.
  3. AA; anaplastic astrocytoma.